Peripartum cardiomyopathy in a previously asymptomatic carrier of duchenne muscular dystrophy

Heart Lung and Circulation

Volumn 22, Issue 8, 2013, Pages 677-681

  Cheng, Victoria E ^a   Prior, David L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

Dilated cardiomyopathy; Duchenne muscular dystrophy

Indexed keywords

ANTIBIOTIC AGENT; BISOPROLOL; C REACTIVE PROTEIN; CARVEDILOL; CREATINE KINASE; FUROSEMIDE; LOW MOLECULAR WEIGHT HEPARIN; PERINDOPRIL; SPIRONOLACTONE; TROPONIN I; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DRUG DOSE TITRATION; DUCHENNE MUSCULAR DYSTROPHY; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; GENETIC SCREENING; HEART LEFT VENTRICLE FAILURE; HEMOPTYSIS; HETEROZYGOTE; HUMAN; LEUKOCYTE COUNT; LUNG EDEMA; MITRAL VALVE REGURGITATION; PERIPARTUM CARDIOMYOPATHY; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PUERPERIUM; SINUS TACHYCARDIA; THORAX PAIN; THORAX RADIOGRAPHY; CARDIOMYOPATHIES; DIET THERAPY; DRUG EFFECTS; GENETICS; HEART STROKE VOLUME; MALE; MUTATION; NEWBORN; PATHOPHYSIOLOGY; PERINATAL PERIOD;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHIES; DIURETICS; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MUSCULAR DYSTROPHY, DUCHENNE; MUTATION; PERIPARTUM PERIOD; STROKE VOLUME;

EID: 84881555697     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2012.11.015     Document Type: Article

References (17)

1. Sliwa K., Hilfiker-Kleiner D., Petrie M.C., Mebazaa A., Pieske B., Buchmann E., et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010, 12(8):767-778. [Epub 2010/08/03].
2. Hilfiker-Kleiner D., Kaminski K., Podewski E., Bonda T., Schaefer A., Sliwa K., et al. A cathepsin D-cleaved 16kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007, 128(3):589-600. [Epub 2007/02/10].
3. Grain L., Cortina-Borja M., Forfar C., Hilton-Jones D., Hopkin J., Burch M. Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscular Disord: NMD 2001, 11(2):186-191. [Epub 2001/03/21].
4. Davies J.E., Winokur T.S., Aaron M.F., Benza R.L., Foley B.A., Holman W.L. Cardiomyopathy in a carrier of Duchenne's muscular dystrophy. J Heart Lung Trans Off Pub Int Soc Heart Trans 2001, 20(7):781-784. [Epub 2001/07/13].
5. Sliwa K., Fett J., Elkayam U. Peripartum cardiomyopathy. Lancet 2006, 368(9536):687-693. [Epub 2006/08/22].
6. Matharu G.S., Oelbaum M.H. Peripartum cardiomyopathy in a patient with hyperprolactinaemia. Postgrad Med J 1984, 60(699):49-51. [Epub 1984/01/01].
7. Sliwa K., Blauwet L., Tibazarwa K., Libhaber E., Smedema J.P., Becker A., et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010, 121(13):1465-1473. [Epub 2010/03/24].
8. Helderman-van den Enden A.T., van den Bergen J.C., Breuning M.H., Verschuuren J.J., Tibben A., Bakker E., et al. Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level?. Clin Genet 2011, 79(3):236-242. [Epub 2010/11/13].
9. Politano L., Nigro V., Nigro G., Petretta V.R., Passamano L., Papparella S., et al. Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. JAMA 1996, 275(17):1335-1338. [Epub 1996/05/01].
10. Hoogerwaard E.M., van der Wouw P.A., Wilde A.A., Bakker E., Ippel P.F., Oosterwijk J.C., et al. Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscular Disord: NMD 1999, 9(5):347-351. [Epub 1999/07/17].
11. Seemann N., Selby K., McAdam L., Biggar D., Kolski H., Goobie S., et al. Symptomatic dystrophinopathies in female children. Neuromuscular Disord: NMD 2011, 21(3):172-177. [Epub 2010/12/28].
12. Elkayam U., Akhter M.W., Singh H., Khan S., Bitar F., Hameed A., et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005, 111(16):2050-2055. [Epub 2005/04/27].
13. Kamakura K. Cardiac involvement of female carrier of Duchenne muscular dystrophy. Intern Med 2000, 39(1):2-3. [Epub 2000/02/16].
14. Cooper W.O., Hernandez-Diaz S., Arbogast P.G., Dudley J.A., Dyer S., Gideon P.S., et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354(23):2443-2451. [Epub 2006/06/09].
15. Alwan S., Polifka J.E., Friedman J.M. Angiotensin II receptor antagonist treatment during pregnancy. Birth Defects Res A Clin Mol Ter 2005, 73(2):123-130. [Epub 2005/01/26].
16. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011, 58(7):659-670. [Epub 2011/08/06].
17. Ellsworth A. Pharmacotherapy of hypertension while breastfeeding. J Hum Lactat Off J Int Lactat Consult Assoc 1994, 10(2):121-124. [Epub 1994/06/01].